Fairchem Organics Ltd · NSE:FAIRCHEMOR
Fairchem Organics — Q4 FY23 Earnings Presentation
16 slides from Fairchem Organics's earnings presentation, May 31, 2023
Slide 1: Stock exchange filing cover letter: Q4 Earnings Presentation
FAIC I TI Regd. Office 253/P & 312, Village Chekhala, Sanand Kadi Highway, - & Works : Taluka SANAND, District: Ahmedabad 382 115, GUJARAT, INDIA. - Phone (Board Nos.) : (02717) 687900, 687901, +91 90163 24095 FAIRCHEM E-mail : cs@fairchem.in A FAIRFAX COMPANY CIN L24200GJ2O19PLC1 29759 Website : ww
Slide 2: Earnings Presentation Q4-FY23/FY23
Earnings Presentation Q4-FY23/FY23
Slide 3: Company at a Glance
Company at a Glance Well entrenched Customer Forward integration to Relationships in Promoted by Fairfax make value added Long lasting Pan India high growth India Holdings and products from current co- Raw Material sourcing industries like backed by experienced product – Monomer capabilities with Pa
Slide 4: Company Overview
Company Overview • Fairchem Organics Ltd. (Fairchem) is engaged in the business of manufacturing of Oleo Chemicals and Nutraceuticals, since the last 25 years. Revenue & EBITDA Margin (In Mn) • It has a state -of-the-art Manufacturing unit which was set up in 1995 and has over the years 6,432 6,480
Slide 5: Fairchem's Competitive Advantage
Fairchem’s Competitive Advantage Major Player in the Indian Oleo Chemical Market Using Renewable Resources • Processing waste from edible oil refining process to produce high value oleo chemicals giving it price advantage • Enjoy Leadership Position in the industry due to barriers to entry • Focus o
Slide 6: ESG Initiatives
ESG Initiatives ENVIRONMENT SOCIAL GOVERNANCE CSR Activites Effluent Method of Disposal • Dr. Jivraj Mehta Smarak Health Foundation • Always be adequately capitalized - Purchase of Ventilator Machine Zero Liquid Discharge by Multi • Not overleverage the balance sheet Water Effect Evaporator and Agit
Slide 7: Key Financial Highlights
g FAIRCHEM Key Financial Highlights
Slide 8: Q4-FY23/FY23 Financial & Operational Highlights
Q4-FY23/FY23 Financial & Operational Highlights Q4-FY23 Financial Performance • The demand from Paint industry had revived to a large extent in Q4-FY23 thereby pushing the sale of Linoleic Acid. INR 1,519 Mn INR 192 Mn 12.64% Revenue from There was marginal improvement in per unit realisation of EBI
Slide 9: Quarterly Financial Performance
Quarterly Financial Performance PARTICULARS (INR Mn) Q4-FY23 Q4-FY22 Y-O-Y Q3-FY23 Q-O-Q Revenue from Operations 1,519 1,776 (14.5)% 1,025 48.2% Total Expenses 1,327 1,589 (16.5)% 989 34.2% EBITDA 192 187 2.7% 36 NA EBITDA Margins (%) 12.64% 10.53% 211 Bps 3.51% 913 Bps Other Income 2 1 NA 3 (33.3)%
Slide 10: YTD Financial Performance
YTD Financial Performance PARTICULARS (INR Mn) FY23 FY22 Y-O-Y Revenue from Operations 6,480 6,432 0.7% Total Expenses 5,756 5,383 6.9% EBITDA 724 1,049 (31.0)% EBITDA Margins (%) 11.17% 16.31% (514) Bps Other Income 7 3 NA Depreciation 82 71 15.5% Finance Cost 63 69 (8.7)% PBT 586 912 (35.7)% Tax 1
Slide 11: Historical Income Statement
Historical Income Statement PARTICULARS (INR Mn) FY20 FY21 FY22 FY23 Revenue from Operations 3,065 3,966 6,432 6,480 Total Expenses 2,581 3,279 5,383 5,756 EBITDA 484 687 1,049 724 EBITDA Margins (%) 15.79% 17.32% 16.31% 11.17% Other Income 66 3 3 7 Depreciation 60 66 71 82 Finance Cost 66 68 69 63
Slide 12: Historical Balance Sheet
Historical Balance Sheet ASSETS FY21 FY22 FY23 EQUITY AND LIABILITIES FY21 FY22 FY23 Non-Current Assets EQUITY Property, Plant and Equipment 1,220 1,363 1,514 Equity Share Capital 130 130 130 Instruments entirely equity in nature Capital work-in-progress 295 420 349 Other Equity 1,557 2,191 2,462 Ri
Slide 13: Historical Cash Flow Statement
Historical Cash Flow Statement PARTICULARS (INR Mn) FY21 FY22 FY23 Cash and Cash Equivalents at Beginning of the year 0.3 0.3 0.1 Cash Flow From Operating Activities 394 405 496 Cash Flow from Investing Activities (228) (342) (145) Cash Flow From Financing Activities (166) (63) (351) Net Inc./(Dec.)
Slide 14: Key Financial Highlights
Key Financial Highlights Revenue (In Mn) EBITDA (In Mn) & EBITDA Margin (%) PAT (In Mn) & PAT Margin (%) 5 Year CAGR - 22% 5 Year CAGR - 16% 5 Year CAGR - 18% 6,432 6,480 1,049 679 724 687 435 3,966 425 3,065 484 347 2,428 2,499 361 338 194 215 17.32% 16.31% 11.32% 10.72% 10.56% 13.92% 14.44% 15.79%
Slide 15: Capital Market Data
Capital Market Data Stock Market Performance (As on 31st March, 2023) Dividend Percentage 60% 130.00% 40% 20% 75% 0% -20% 35.00% 25.00% -40% 15.00% 15.00% -60% Apr-22 May-22 Jun-22 Jul-22 Aug-22 Sep-22 Oct-22 Nov-2 2 Dec-22 Jan -23 Feb-23 Mar-23 Fairchem Organics Sensex FY18 FY19 FY20 FY21 FY22 FY23
Slide 16: Disclaimer
Disclaimer Fairchem Organics Limited Disclaimer: The information contained in this presentation is only current as of its date. All actions and statements made herein or otherwise shall be subject to the applicable laws and regulations as amended from time to time. There is no representation that al